김명수
#유방암#전이암
|
학력
2007.02 이화여자대학교 의과대학 학사
2011.08 이화여자대학교 의과대학원 석사
2016.07 가톨릭대학교 의과대학원 박사수료
2011.08 이화여자대학교 의과대학원 석사
2016.07 가톨릭대학교 의과대학원 박사수료
경력
2007~2008 이화여대 의과대학 부속 목동병원 인턴
2008~2012 이화여대 의과대학 부속 목동병원 방사선종양학과 전공의
2012~2013 국립암센터 양성자치료센터 전임의
2013~2015 가톨릭대학교 인천성모병원 방사선종양학과 임상강사
2015~ 現 가톨릭대학교 인천성모병원 방사선종양학과 임상조교수
방사선종양학과 과장, 방사선치료센터장
2008~2012 이화여대 의과대학 부속 목동병원 방사선종양학과 전공의
2012~2013 국립암센터 양성자치료센터 전임의
2013~2015 가톨릭대학교 인천성모병원 방사선종양학과 임상강사
2015~ 現 가톨릭대학교 인천성모병원 방사선종양학과 임상조교수
방사선종양학과 과장, 방사선치료센터장
논문
Kim M, Lee J, Ha B, Lee R, Lee KJ, Suh HS. Factors predicting radiation pneumonitis in locally advanced non-small cell lung cancer. Radiat Oncol J. 2011;29: 181-190.
김동영,이지혜,김명수,하보람,이천희,김소영,안소현,이레나. CR 시스템을 이용한 방사선 종양학과의 Filmless 환경 구축. 의학물리 제22권 제3호 (2011년 9월) pp.155-162
Baek J, Huh J, Kim M, An SH, Oh Y, Kim D, Chung K, Cho S, Lee R. Accuracy of volume measurement using 3D ultrasound and development of CT-3D US image fusion algorithm for prostate cancer radiotherapy. Med Phys. 2013;40: 021704.
Kim M, Kim SW, Lee SU, Lee NK, Jung SY, Kim TH, Lee ES, Kang HS, Shin KH. A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy. Int J Radiat Oncol Biol Phys. 2013;86: 498-503.
Kim M, Son SH, Won YK, Kay CS. Stereotactic ablative radiotherapy for oligometastatic disease in liver. Biomed Res Int. 2014;2014: 340478.
Jung SY, Shin KH, Kim M, Chung SH, Lee S, Kang HS, Lee ES, Kwon Y, Lee KS, Park IH, Ro J. Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients. Breast Cancer Res Treat. 2014;148: 91-98.
Kim M, Park IH, Lee KS, Ro J, Jung SY, Lee S, Kang HS, Lee ES, Kim TH, Cho KH, Shin KH. Breast Cancer-Related Lymphedema after Neoadjuvant Chemotherapy. Cancer Res Treat. 2014.
Yoon MS, Park W, Huh SJ, Kim HJ, Kim YS, Kim YB, Kim JY, Lee JH, Kim HJ, Cha J, Kim JH, Kim J, Yoon WS, Choi JH, Chun M, Choi Y, Chang SK, Lee KK, Kim M. multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17). Gynecol Oncol. 2015 Sep;138(3):519-25.
Jang WI, Kim MS, Lim JS, Yoo HJ, Seo YS, Han CJ, Park SC, Kay CS, Kim M, Jang HS, Lee DS, Chang AR, Park HJ. Survival Advantage Associated with Metformin Usage in Hepatocellular Carcinoma Patients Receiving Radiotherapy: A Propensity Score Matching Analysis. Anticancer Res. 2015 Sep;35(9):5047-54.
Yoon MS, Huh SJ, Kim HJ, Kim YS, Kim YB, Kim JY, Lee JH, Kim HJ, Cha J, Kim JH, Kim J, Yoon WS, Choi JH, Chun M, Choi Y, Lee KK, Kim M, Jeong JU, Chang SK, Park W. Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma. Cancer Res Treat. 2015
김동영,이지혜,김명수,하보람,이천희,김소영,안소현,이레나. CR 시스템을 이용한 방사선 종양학과의 Filmless 환경 구축. 의학물리 제22권 제3호 (2011년 9월) pp.155-162
Baek J, Huh J, Kim M, An SH, Oh Y, Kim D, Chung K, Cho S, Lee R. Accuracy of volume measurement using 3D ultrasound and development of CT-3D US image fusion algorithm for prostate cancer radiotherapy. Med Phys. 2013;40: 021704.
Kim M, Kim SW, Lee SU, Lee NK, Jung SY, Kim TH, Lee ES, Kang HS, Shin KH. A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy. Int J Radiat Oncol Biol Phys. 2013;86: 498-503.
Kim M, Son SH, Won YK, Kay CS. Stereotactic ablative radiotherapy for oligometastatic disease in liver. Biomed Res Int. 2014;2014: 340478.
Jung SY, Shin KH, Kim M, Chung SH, Lee S, Kang HS, Lee ES, Kwon Y, Lee KS, Park IH, Ro J. Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients. Breast Cancer Res Treat. 2014;148: 91-98.
Kim M, Park IH, Lee KS, Ro J, Jung SY, Lee S, Kang HS, Lee ES, Kim TH, Cho KH, Shin KH. Breast Cancer-Related Lymphedema after Neoadjuvant Chemotherapy. Cancer Res Treat. 2014.
Yoon MS, Park W, Huh SJ, Kim HJ, Kim YS, Kim YB, Kim JY, Lee JH, Kim HJ, Cha J, Kim JH, Kim J, Yoon WS, Choi JH, Chun M, Choi Y, Chang SK, Lee KK, Kim M. multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17). Gynecol Oncol. 2015 Sep;138(3):519-25.
Jang WI, Kim MS, Lim JS, Yoo HJ, Seo YS, Han CJ, Park SC, Kay CS, Kim M, Jang HS, Lee DS, Chang AR, Park HJ. Survival Advantage Associated with Metformin Usage in Hepatocellular Carcinoma Patients Receiving Radiotherapy: A Propensity Score Matching Analysis. Anticancer Res. 2015 Sep;35(9):5047-54.
Yoon MS, Huh SJ, Kim HJ, Kim YS, Kim YB, Kim JY, Lee JH, Kim HJ, Cha J, Kim JH, Kim J, Yoon WS, Choi JH, Chun M, Choi Y, Lee KK, Kim M, Jeong JU, Chang SK, Park W. Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma. Cancer Res Treat. 2015
저서
저서 내용이 없습니다.
보도자료
종양 위치 정밀 확인… 췌장암 등 '맞춤형' 방사선치료
http://health.chosun.com/site/data/html_dir/2020/03/17/2020031702747.html
http://health.chosun.com/site/data/html_dir/2020/03/17/2020031702747.html
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.